- Home
- CVRX vs TEAF Comparison
CVRX vs TEAF Comparison
Compare CVRX & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- TEAF
- Stock Information
- Founded
- CVRX 2000
- TEAF 2017
- Country
- CVRX United States
- TEAF United States
- Employees
- CVRX N/A
- TEAF N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- CVRX Health Care
- TEAF Finance
- Exchange
- CVRX Nasdaq
- TEAF Nasdaq
- Market Cap
- CVRX 174.4M
- TEAF 163.0M
- IPO Year
- CVRX 2021
- TEAF N/A
- Fundamental
- Price
- CVRX $7.56
- TEAF $12.10
- Analyst Decision
- CVRX Buy
- TEAF
- Analyst Count
- CVRX 7
- TEAF 0
- Target Price
- CVRX $14.50
- TEAF N/A
- AVG Volume (30 Days)
- CVRX 302.9K
- TEAF 56.1K
- Earning Date
- CVRX 08-04-2025
- TEAF 01-01-0001
- Dividend Yield
- CVRX N/A
- TEAF 9.20%
- EPS Growth
- CVRX N/A
- TEAF N/A
- EPS
- CVRX N/A
- TEAF N/A
- Revenue
- CVRX $52,870,000.00
- TEAF N/A
- Revenue This Year
- CVRX $11.53
- TEAF N/A
- Revenue Next Year
- CVRX $18.61
- TEAF N/A
- P/E Ratio
- CVRX N/A
- TEAF N/A
- Revenue Growth
- CVRX 25.62
- TEAF N/A
- 52 Week Low
- CVRX $4.30
- TEAF $11.11
- 52 Week High
- CVRX $18.55
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- CVRX 50.10
- TEAF 50.96
- Support Level
- CVRX $8.10
- TEAF $12.05
- Resistance Level
- CVRX $8.81
- TEAF $12.27
- Average True Range (ATR)
- CVRX 0.58
- TEAF 0.11
- MACD
- CVRX -0.06
- TEAF -0.02
- Stochastic Oscillator
- CVRX 29.89
- TEAF 36.90
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.